After Appeal, Court Rules Juul Can Still Sell E-Cigarettes for Now

MONDAY, June 27, 2022 (HealthDay News) -- A federal appeals court has ruled that for now, Juul Labs can continue to sell its electronic cigarettes on the U.S. market.
The Friday ruling came in response to the company seeking a temporary emergency hold while it appeals a ban of its products that was issued Thursday by the U.S. Food and Drug Administration.
The e-cigarette maker had asked the court to pause what it called an "extraordinary and unlawful action" by the FDA that would have required it to immediately halt its business, the Associated Press reported.
When issuing the ban last week, the FDA said Juul's application left regulators with significant questions and did not include enough information to evaluate any potential health risks. Meanwhile, Juul said it submitted enough information and data to address all issues raised.
The products include the Juul vaping device and four types of Juul pods: pods labeled Virginia Tobacco flavor at nicotine concentrations of 5 and 3 percent, and menthol-flavored pods at nicotine concentrations of 5 and 3 percent, the FDA said.
The FDA has already banned the sale of fruit-flavored e-cigarettes after critics claimed the products targeted teens. Regulators have since been reviewing thousands of applications for vaping products after tightening their oversight of the electronic cigarette market.
Related Posts
Cómo eliminar el mal aliento
LUNES, 24 de abril de 2023 (HealthDay News) -- Más o menos 1 de cada 4 personas...
Multisystem Abnormalities Persist After COVID-19 Hospitalization
TUESDAY, May 31, 2022 (HealthDay News) -- Patients after hospitalization with...
Did the Pandemic Spur Permanent Decline in Americans’ Daily Steps?
TUESDAY, March 21, 2023 (HealthDay News) -- If you feel like the pandemic made...
La semana pasada, casi 600,000 niños de EE. UU. tenían COVID
MIÉRCOLES, 12 de enero de 2022 (HealthDay News) -- Un nuevo informe muestra que...